文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

光子直肠NTCP模型在质子放疗中的跨模态适用性

Cross-modality applicability of rectal normal tissue complication probability models from photon- to proton-based radiotherapy.
PubMed 文献 · Radiother Oncol · 2019-10-17

本研究基于1151例接受被动散射质子治疗和159例接受三维适形四野光子治疗的前列腺癌患者数据,评估光子直肠正常组织并发症概率(NTCP)模型在质子治疗中的适用性。结果显示,光子直肠NTCP模型在质子队列中会高估或低估临床观察到的胃肠道并发症,取决于终点选择(所有参数集P<0.05);六个光子NTCP模型中有四个对光子结局数据拟合良好(P>0.05)。结论提示NTCP模型和参数在跨机构、跨治疗模态应用前需仔细验证。

要点

  • 光子直肠NTCP模型用于质子队列时,对胃肠道并发症的预测存在高估或低估,所有参数集P<0.05。
  • 六个光子NTCP模型中有四个对光子结局数据拟合良好(P>0.05)。
  • NTCP模型和参数在跨机构、跨治疗模态临床使用前应仔细验证。

核心结论

  • 光子直肠NTCP模型在质子治疗队列中高估或低估临床观察到的胃肠道并发症,取决于终点选择,所有参数集P<0.05。
  • 六个光子NTCP模型中有四个对光子结局数据拟合良好(P>0.05)。
  • NTCP模型和参数跨机构、跨治疗模态应用前需仔细验证。

研究设计与样本

  • 分析1151例接受被动散射质子治疗和159例接受常规三维适形四野光子治疗的前列腺癌患者的治疗计划与发病率数据。
  • 前瞻性收集胃肠道发病率(≥2级),质子组共184例事件(医学和程序性),光子组共12例事件(仅程序性)。
  • 提取两组患者直肠剂量体积直方图,作为两种不同NTCP模型的输入,最多使用六种已发表的光子参数集。

主要发现

  • 光子直肠NTCP模型在质子队列中高估或低估临床观察到的胃肠道并发症,取决于终点选择,所有参数集P<0.05(两种发病率分类均如此)。
  • 六个光子NTCP模型中有四个对光子结局数据拟合良好(P>0.05)。
  • 队列和模态之间的发病率预测存在较大差异。

临床怎么用

  • 光子NTCP模型用于质子治疗前应重新验证,不可直接套用。
  • 选择NTCP模型参数时需考虑治疗模态和终点定义的影响。

局限性

  • 光子队列事件数较少(仅12例程序性事件),可能影响模型拟合评估。
  • 质子治疗采用被动散射技术,结论可能不适用于其他质子技术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Proton therapy (PT) is currently being studied to improve normal tissue (NT) sparing beyond what can be achieved with conventional photon-based therapy. Compared to photons, PT dose distributions have a reduced NT low-to-intermediate 'dose bath' and a different biological effectiveness, questioning the applicability of photon-based NT complication probability (NTCP) models to PT. The aim of this study was to assess the applicability of photon-based NTCP models to rectum morbidity outcomes following PT. MATERIALS AND METHODS: Treatment planning and morbidity data from 1151 prostate cancer patients treated with passive scattering PT and from 159 patients treated with conventional 3D conformal four-field photon therapy were analysed. Prospectively scored gastrointestinal morbidities (grade >=2) were analysed, with a total of 184 events (protons; medical and procedural) and 12 events (photons; procedural only), respectively. Rectal dose volume histograms were extracted for all patients in both cohorts and used as input to two different NTCP models, with up to six different published photon-based parameter sets. RESULTS: Photon-based rectal NTCP models either over- or underestimated the clinically observed gastrointestinal morbidity when used on the proton cohort, depending on the choice of endpoint (p < 0.05 for all parameter sets, for both morbidity classifications). Four of the six photon-based NTCP models showed a good fit to the photon outcome data (p > 0.05). CONCLUSION: There were large differences in morbidity predictions between cohorts and modalities, indicating that the validity of NTCP models and parameters across institutions and treatment modalities should be carefully investigated prior to clinical application.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Pedersen J, Flampouri S, Bryant C, et al. Cross-modality applicability of rectal normal tissue complication probability models from photon- to proton-based radiotherapy. Radiother Oncol. 2019. PMID: 31630864. doi:10.1016/j.radonc.2019.09.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。